Computational analysis of activity and selectivity cliffs.

The exploration of structure-activity relationships (SARs) is a major challenge in medicinal chemistry and usually focuses on compound potency for individual targets. However, selectivity of small molecules that are active against related targets is another critical parameter in chemical lead optimization. Here, an integrative approach for the systematic analysis of SARs and structure-selectivity relationships (SSRs) of small molecules is presented. The computational methodology is described and a cathepsin inhibitor set is used to discuss key aspects of the analysis. Combining a numerical scoring scheme and graphical visualization of molecular networks, the approach enables the identification of different local SAR and SSR environments. Comparative analysis of these environments reveals variable relationships between molecular structure, potency, and selectivity. Furthermore, key compounds are identified that are involved in the formation of activity and/or selectivity cliffs and often display structural features that determine compound selectivity.

[1]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[2]  J. H. Ward Hierarchical Grouping to Optimize an Objective Function , 1963 .

[3]  Mathias Wawer,et al.  Navigating structure-activity landscapes. , 2009, Drug discovery today.

[4]  J. Bajorath,et al.  Methods for Computer‐Aided Chemical Biology. Part 3: Analysis of Structure–Selectivity Relationships through Single‐ or Dual‐Step Selectivity Searching and Bayesian Classification , 2008, Chemical biology & drug design.

[5]  Jürgen Bajorath,et al.  From Structure–Activity to Structure–Selectivity Relationships: Quantitative Assessment, Selectivity Cliffs, and Key Compounds , 2009, ChemMedChem.

[6]  J. Bajorath,et al.  Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. , 2008, Journal of medicinal chemistry.

[7]  Jürgen Bajorath,et al.  Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes. , 2007, Chemistry & biology.

[8]  J. Bajorath Computational analysis of ligand relationships within target families. , 2008, Current opinion in chemical biology.

[9]  J. Bajorath,et al.  SAR index: quantifying the nature of structure-activity relationships. , 2007, Journal of medicinal chemistry.

[10]  J. Bajorath,et al.  Systematic computational analysis of structure-activity relationships: concepts, challenges and recent advances. , 2009, Future medicinal chemistry.

[11]  Marvin Johnson,et al.  Concepts and applications of molecular similarity , 1990 .

[12]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.